Response to "Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study".

Kumar, Satesh; Raja, Roomi

Kumar, Satesh; Raja, Roomi.

Kumar S; Shaheed Mohtarma Benazir Bhutto Medical College Liyari, Karachi, Parsa citi Block E Floor 5th, Flat 501 Near Police Headquarter, Garden East Karachi, Pakistan. Kewlanisatish@gmail.com.
Raja R; Ziauddin University, Karachi, Pakistan.

Acta Diabetol ; 59(6): 869-870, 2022 06.

Article in English | MEDLINE | ID: covidwho-1729313

Subject(s)

COVID-19; Diabetes Mellitus, Type 2; Metformin; Cohort Studies; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/drug therapy; Diabetes Mellitus, Type 2/epidemiology; Humans; Hypoglycemic Agents/therapeutic use; Metformin/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / COVID-19 / Metformin Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Acta Diabetol Journal subject: Endocrinology Year: 2022 Document Type: Article Affiliation country: S00592-022-01861-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google